A detailed history of Chase Investment Counsel Corp transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Chase Investment Counsel Corp holds 1,009 shares of WST stock, worth $336,218. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,009
Previous 1,009 -0.0%
Holding current value
$336,218
Previous $332,000 9.04%
% of portfolio
0.1%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$314.68 - $395.94 $9,755 - $12,274
-31 Reduced 2.98%
1,009 $332,000
Q4 2023

Feb 05, 2024

BUY
$318.29 - $392.21 $331,021 - $407,898
1,040 New
1,040 $366,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.